- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Health Services scores financing
Imaging services firm Diagnostic Health Services (DHS) this month secured a financing deal with UniCapital of Miami. As the Dallas firm’s primary lender, UniCapital has agreed to provide short-term financing to DHS to help the firm cover debt on
Imaging services firm Diagnostic Health Services (DHS) this month secured a financing deal with UniCapital of Miami. As the Dallas firms primary lender, UniCapital has agreed to provide short-term financing to DHS to help the firm cover debt on which it has defaulted. DHS remains in default of its senior credit agreements.
Also this month, Diagnostic Health Services hired a national consulting firm, Glass & Associates, which helps companies evaluate their restructuring, downsizing, strategic alliance, or sale options. The move comes after an attempt last year to merge with Medical Alliance collapsed after both companies boards of directors decided they couldnt deliver the anticipated value of the proposed deal to shareholders (SCAN 8/18/99). After the merger fell through, DHS focused on ways to improve its balance sheet by restructuring its senior and subordinated debt positions and began to seek options for raising capital. The companys stock was delisted from NASDAQ National Market on Aug. 11, and now trades on the Over the Counter bulletin board.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
